Chronic obstructive pulmonary disease (COPD) is an inflammatory airways disease with
limited therapeutic options. We have previously shown that mesenchymal stromal cell (MSC) …

Multiparametric quantitative imaging biomarkers (QIBs) offer distinct advantages over single,
univariate descriptors because they provide a more complete measure of complex …

There is a large gap between diagnostic needs and diagnostic access across much of sub-
Saharan Africa (SSA), particularly for infectious diseases that inflict a substantial burden of …

Background It is required to consider multiple biomarkers simultaneously to predict
sarcopenia and to understand its complex pathological mechanisms. This study aimed to …

Do we need biomarkers of lung damage and infection: For what purpose and how should
they be used properly? Biomarkers of lung damage can be used for diagnosis, risk …

Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease
characterised by airflow obstruction and other morbidities such as respiratory symptoms …

Background There is a strong need for biomarkers to better characterize individuals with
COPD and to take into account the heterogeneity of COPD. The blood protein sRAGE has …

Antibodies are indispensable tools in biomedical research, but their size, complexity, and
sometimes lack of reproducibility created a need for the development of alternative binders …

Background There is a link between exposure to air pollution and the increased prevalence
of chronic obstructive pulmonary disease (COPD) and declining pulmonary function, but the …

Lung disease progression in alpha-1 antitrypsin deficiency (AATD) is heterogenous and
manifests in different ways. Blood biomarkers are an attractive method of monitoring …